Literature DB >> 20936781

Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS.

Peter Juhasz1, Moira Lynch, Mahadevan Sethuraman, Jennifer Campbell, Wade Hines, Manuel Paniagua, Leijun Song, Mahesh Kulkarni, Aram Adourian, Yu Guo, Xiaohong Li, Stephen Martin, Neal Gordon.   

Abstract

A quantitative proteomics workflow was implemented that provides extended plasma protein coverage by extensive protein depletion in combination with the sensitivity and breadth of analysis of two-dimensional LC-MS/MS shotgun analysis. Abundant proteins were depleted by a two-stage process using IgY and Supermix depletion columns in series. Samples are then extensively fractionated by two-dimensional chromatography with fractions directly deposited onto MALDI plates. Decoupling sample fractionation from mass spectrometry facilitates a targeted MS/MS precursor selection strategy that maximizes measurement of a consistent set of peptides across experiments. Multiplexed stable isotope labeling provides quantification relative to a common reference sample and ensures an identical set of peptides measured in the set of samples (set of eight) combined in a single experiment. The more extensive protein depletion provided by the addition of the Supermix column did not compromise overall reproducibility of the measurements or the ability to reliably detect changes in protein levels between samples. The implementation of this workflow is presented for a case study aimed at generating molecular signatures for prediction of first heart attack.

Mesh:

Substances:

Year:  2010        PMID: 20936781     DOI: 10.1021/pr100659e

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  11 in total

Review 1.  IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.

Authors:  Tujin Shi; Jian-Ying Zhou; Marina A Gritsenko; Mahmud Hossain; David G Camp; Richard D Smith; Wei-Jun Qian
Journal:  Methods       Date:  2011-09-10       Impact factor: 3.608

Review 2.  Quantitative proteomics in cardiovascular research: global and targeted strategies.

Authors:  Xiaomeng Shen; Rebeccah Young; John M Canty; Jun Qu
Journal:  Proteomics Clin Appl       Date:  2014-07-14       Impact factor: 3.494

3.  Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative.

Authors:  Xiaoyan Yin; Subha Subramanian; Shih-Jen Hwang; Christopher J O'Donnell; Caroline S Fox; Paul Courchesne; Pieter Muntendam; Neal Gordon; Aram Adourian; Peter Juhasz; Martin G Larson; Daniel Levy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

4.  In-Depth, Reproducible Analysis of Human Plasma Using IgY 14 and SuperMix Immunodepletion.

Authors:  Lynn A Beer; Bonnie Ky; Kurt T Barnhart; David W Speicher
Journal:  Methods Mol Biol       Date:  2017

5.  Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics.

Authors:  Bhavinkumar B Patel; Carlos A Barrero; Alan Braverman; Phillip D Kim; Kelly A Jones; Dian Er Chen; Russell P Bowler; Salim Merali; Steven G Kelsen; Anthony T Yeung
Journal:  J Proteome Res       Date:  2012-10-29       Impact factor: 4.466

6.  Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study.

Authors:  Richard S Finkel; Thomas O Crawford; Kathryn J Swoboda; Petra Kaufmann; Peter Juhasz; Xiaohong Li; Yu Guo; Rebecca H Li; Felicia Trachtenberg; Suzanne J Forrest; Dione T Kobayashi; Karen S Chen; Cynthia L Joyce; Thomas Plasterer
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

7.  A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery.

Authors:  Amit Kumar Yadav; Gourav Bhardwaj; Trayambak Basak; Dhirendra Kumar; Shadab Ahmad; Ruby Priyadarshini; Ashish Kumar Singh; Debasis Dash; Shantanu Sengupta
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

8.  Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers.

Authors:  Maria A Sleddering; Albert J Markvoort; Harish K Dharuri; Skhandhan Jeyakar; Marieke Snel; Peter Juhasz; Moira Lynch; Wade Hines; Xiaohong Li; Ingrid M Jazet; Aram Adourian; Peter A J Hilbers; Johannes W A Smit; Ko Willems Van Dijk
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 9.  Revisiting biomarker discovery by plasma proteomics.

Authors:  Philipp E Geyer; Lesca M Holdt; Daniel Teupser; Matthias Mann
Journal:  Mol Syst Biol       Date:  2017-09-26       Impact factor: 11.429

10.  Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow.

Authors:  Zhiyun Cao; Sachin Yende; John A Kellum; Renã A S Robinson
Journal:  Int J Proteomics       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.